Tag: NovaMedica

NovaMedica is a modern Russian pharmaceutical company established in 2012 by leading U.S. venture capital firm Domain Associates LLC and RUSNANO, an investment fund that implements state policy for the development of Russia’s high-technology industries.

NovaMedica has developed a well-established infrastructure to promote and sell pharmaceutical products in the Russian market. Its portfolio currently includes 25 products in ophthalmology and gastroenterology.

NovaMedica’s strategy is focused on the search, registration and localization in Russia of innovative pharmaceutical products and technologies, as well as the development of the company’s own research and development activities and the establishment of a GMP-compliant pharmaceutical production facility in Russia.

NovaMedica is currently building a Technology Center in Moscow that will include R&D laboratories and production facilities for advanced technologies previously unavailable on the Russian pharmaceutical market.

NovaMedica signs the largest SPIC in pharma industry

novamedica
NovaMedica, a Russian pharmaceutical company and investment project of Rusnano, concluded a special investment contract (SPIC) with the Russian Ministry of Industry and Trade and Kaluga region.

A new training center will be established in NovaMedica Innotech

nova medica
NovaMedica has announced the collaboration in the area of knowledge and technology transfer between NovaMedica Innotech, an R&D center, and Evonik, a German company

New investments will accelerate phase III clinical trials of Acebilustat

pharma
RMI Partners, a Russian venture company and one of the largest investors in Russia and Eastern Europe in the area of biotechnology, announced its participation in the next round of investments into Celtaxsys

NovaMedica INNOTECH R&D center meets Russian GMP standards

novamedica
Novamedica announced that it received the conclusion on the compliance of the production site of NovaMedica Innotech R&D center with the Russian GMP standards.

Authorities approve the application of NovaMedica for a new production facility

novamedica
NovaMedica announced the approval of the Inter-Agency SPIC under the investment project aimed at establishing a pharmaceutical plant

NovaMedica receives a license for production site at its R&D center

novamedica
NovaMedica received a license from the FBI SID & GP for a pilot production site at its R&D center

Construction of a new pharmaceutical plant started in Vorsino Industrial Park

vorsino-novamedica
On May 30, Vorsino Industrial Park in the Kaluga region hosted an official ceremony to mark the start of construction of an advanced biopharmaceutical production facility

NovaMedica opens a new technology center

novamedica
NovaMedica, a Russian pharmaceutical company, opened a technology center for development and pilot production of innovative medicinal products. It includes a set of research laboratories and productio...

The clinical studies of the first NovaMedica drug have been successfully completed

research
The Russian pharmaceutical company NovaMedica has successfully completed the clinical trials of the first drug developed by its own R&D-division. The new drug is a gel for the treatment and allevi...

Pfizer and NovaMedica complete strategic partnership

Pfizer and NovaMedica
US pharma giant Pfizer and Russia’s NovaMedica, a company established in 2012 by Russian high-technology investment fund Rusnano and American healthcare fund Domain Associates, have completed the last...

“Legislative and regulatory environment in the pharmaceutical industry” has started

NovaMedica - Educational Project
On December 1st, the interdisciplinary educational project "Legislative and regulatory environment in the pharmaceutical industry" has been launched in Russia at the Faculty of Law of the National Res...